Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Citations Over TimeTop 1% of 2018 papers
Abstract
Type 2 diabetes (T2D) is a very common disease in humans. Here we conduct a meta-analysis of genome-wide association studies (GWAS) with ~16 million genetic variants in 62,892 T2D cases and 596,424 controls of European ancestry. We identify 139 common and 4 rare variants associated with T2D, 42 of which (39 common and 3 rare variants) are independent of the known variants. Integration of the gene expression data from blood (n = 14,115 and 2765) with the GWAS results identifies 33 putative functional genes for T2D, 3 of which were targeted by approved drugs. A further integration of DNA methylation (n = 1980) and epigenomic annotation data highlight 3 genes (CAMK1D, TP53INP1, and ATP5G1) with plausible regulatory mechanisms, whereby a genetic variant exerts an effect on T2D through epigenetic regulation of gene expression. Our study uncovers additional loci, proposes putative genetic regulatory mechanisms for T2D, and provides evidence of purifying selection for T2D-associated variants.
Related Papers
- → Estimating the causal tissues for complex traits and diseases(2017)240 cited
- → Diversity and dynamics of DNA methylation: epigenomic resources and tools for crop breeding(2019)50 cited
- Coanalysis of GWAS with eQTLs reveals disease-tissue associations.(2012)
- → rs2072135, a low‐penetrance variant for chronic lymphocytic leukaemia?(2013)2 cited
- → P3‐016: Overlap of gwas loci and expression quantitative trait loci (eQTL) in Alzheimer's disease(2015)